Ubs Group Ag Enanta Pharmaceuticals Inc Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Group Ag holds 20,315 shares of ENTA stock, worth $263,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,315

Previous 21,230 4.31%

Holding current value

$263,485

Previous $199,000 77.89%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$10.08 - $17.46 $9,223 - $15,975	-915 Reduced 4.31%	20,315 $354,000
Q4 2023 Feb 09, 2024	BUY	$8.18 - $10.78 $67,664 - $89,172	8,272 Added 63.84%	21,230 $199,000
Q3 2023 Nov 09, 2023	SELL	$11.09 - $22.13 $338,655 - $675,783	-30,537 Reduced 70.21%	12,958 $144,000
Q2 2023 Aug 11, 2023	BUY	$20.68 - $39.85 $686,224 - $1.32 Million	33,183 Added 321.79%	43,495 $930,000
Q1 2023 May 12, 2023	SELL	$38.82 - $54.59 $1.08 Million - $1.51 Million	-27,704 Reduced 72.87%	10,312 $417,000

Q4 2022 Feb 08, 2023	BUY	$40.77 - $53.73 $1.46 Million - $1.93 Million	35,838 Added 1645.45%	38,016 $1.77 Million
Q3 2022 Nov 10, 2022	SELL	$48.29 - $71.27 $482,948 - $712,771	-10,001 Reduced 82.12%	2,178 $113,000
Q2 2022 Aug 10, 2022	SELL	$38.13 - $76.93 $500,456 - $1.01 Million	-13,125 Reduced 51.87%	12,179 $576,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $844,263 - $1.12 Million	-15,060 Reduced 37.31%	25,304 $1.8 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $551,280 - $891,811	9,159 Added 29.35%	40,364 $3.02 Million
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $828,234 - $1.18 Million	20,191 Added 183.32%	31,205 $1.77 Million
Q2 2021 Aug 13, 2021	SELL	$43.76 - $53.11 $665,852 - $808,121	-15,216 Reduced 58.01%	11,014 $485,000
Q1 2021 May 12, 2021	BUY	$41.69 - $54.95 $1.09 Million - $1.44 Million	26,136 Added 27804.26%	26,230 $1.29 Million
Q4 2020 Feb 11, 2021	BUY	$41.16 - $47.47 $3,869 - $4,462	94 New	94 $4,000
Q3 2020 Nov 12, 2020	SELL	$43.36 - $53.53 $19,772 - $24,409	-456 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$46.37 - $57.58 $206,207 - $256,058	-4,447 Reduced 90.7%	456 $23,000
Q1 2020 May 01, 2020	SELL	$40.22 - $62.0 $39,817 - $61,380	-990 Reduced 16.8%	4,903 $252,000
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $1.26 Million - $1.44 Million	-21,680 Reduced 78.63%	5,893 $364,000
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $1.28 Million - $1.88 Million	21,376 Added 344.94%	27,573 $1.66 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $493,409 - $590,817	6,069 Added 4741.41%	6,197 $523,000
Q1 2019 May 14, 2019	SELL	$69.08 - $105.66 $2.11 Million - $3.22 Million	-30,489 Reduced 99.58%	128 $13,000
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $1.2 Million - $1.55 Million	18,296 Added 148.49%	30,617 $2.17 Million
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $636,677 - $941,456	7,450 Added 152.95%	12,321 $1.05 Million
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $1.87 Million - $2.76 Million	-22,898 Reduced 82.46%	4,871 $565,000
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $1.49 Million - $2.37 Million	25,706 Added 1246.05%	27,769 $2.25 Million
Q4 2017 Feb 14, 2018	SELL	$45.65 - $59.37 $245,733 - $319,588	-5,383 Reduced 72.29%	2,063 $121,000
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $270,108 - $333,450	7,125 Added 2219.63%	7,446 $349,000
Q2 2017 Aug 14, 2017	BUY	N/A	50 Added 18.45%	321 $12,000
Q1 2017 Nov 14, 2017	BUY	N/A	271	271 $8,000

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.7M

Call Options Held

9.4K

Put Options Held

3.3K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $269M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account